Eyetube Podcasts

The next generation of therapy for DME patients will require looking beyond the VEGF pathway. In the phase 2 BOULEVARD study, researchers are assessing the safety and efficacy of the angiopoietin-2 mediator faricimab (Roche/Genentech) for the treatment of DME. Could the angiopoietin pathway present a new option for patients? Karl Csaky, MD, PhD, sits down with NRR to review data from the study, which were shared at this year's AAO Annual Meeting Late Breakers session.

In this special Thanksgiving episode of Ophthalmology Off the Grid, host Blake Williamson, MD, MPH, invites his colleagues to join him in expressing their gratitude. Hear from Dr. Williamson; Richard L. Lindstrom, MD; Evan Schoenberg, MD; Iqbal Ike K. Ahmed, MD, FRCSC; and Zaina Al-Mohtaseb, MD, on what has them feeling thankful in these particularly challenging times.

Gerami Seitzman, MD, Medical Director of the Francis I. Proctor Foundation at the University of California, San Francisco, shares how she and her colleagues developed a drive-through IOP screening service for patients whose care was interrupted by COVID-19, as featured in the September/October 2020 issue of Glaucoma Today.

In this podcast episode, Karolinne Rocha, MD, PhD*, and Elizabeth Yeu, MD, discuss the field of ocular biometry, including useful IOL power calculation formulas, as well as considerations taken for post-LASIK eyes and patients with astigmatism. They also review how they utilize the TECNIS SymfonyTM Extended Range of Vision IOLs (Johnson & Johnson Vision) for their patients.*Drs. Karolinne Rocha and Elizabeth Yeu are paid consultants of Johnson & Johnson Surgical Vision, Inc.

Retinal arteriolar macroaneurysm (RAM) usually regresses spontaneously, but can lead to irreversible vision loss if regression does not occur. Could anti-VEGF therapy be an option for these patients? J. Fernando Arevalo, MD, PhD, joins NRR to discuss data from a study that asked that question. He presented the data at this year's AAO Annual Meeting.

In this episode of the Survive & Thrive series, Gary Wörtz, MD, is joined by Nandini Venkateswaran, MD; Dagny Zhu, MD; and guest Preeya Gupta, MD, to talk about one of the big decisions faced by young ophthalmologists: private practice or academia? They weigh the pros and cons of each career path and share their own experiences in navigating this choice.

The burden of anti-VEGF therapy is particularly high in DME patients, many of whom are young, in the workforce, and unable to easily maintain monthly therapy. Could the antibody biopolymer conjugate KSI-301 (Kodiak Sciences) alleviate that burden while maintaining the outcomes experienced with anti-VEGF therapy? Arshad M. Khanani, MD, MA, shares the results of the phase 1B, long-term, multidose study that was presented at this year's AAO Annual Meeting Late Breakers session.

NRR's miniseries "The Art of Drug Choice: Wet AMD and the Latest Data" wraps up with moderator Dr. Khanani and panelists Drs. Fuller, London, and Weng discussing safety data. How have safety considerations changed in the wet AMD treatment landscape, and how do clinicians balance the risks and rewards of switching to a new agent? Additionally, Dr. Khanani closes out the series with the case of a patient whose disease stopped responding after a decade of anti-VEGF therapy. Listen here to learn how he approached the case.

This NRR miniseries "The Art of Drug Choice: Wet AMD and the Latest Data" continues as Dr. Khanani and the roundtable participants Drs. Fuller, London, and Weng review the wet AMD pipeline with a focus on anti-Ang-2 therapy (faricimab, Roche/Genentech) and gene therapy (RGX-314, RegenxBio and ADVM-022, Adverum Biotechnologies). After the break, Dr. London shares the case of a patient with wet AMD who experienced a ceiling of response to anti-VEGF therapy. Did a switch to brolucizumab (Beovu, Novartis) result a change?

In episode 2 of the NRR miniseries "The Art of Drug Choice: Wet AMD and the Latest Data," Dr. Khanani and roundtable participants Drs. Fuller, London, and Weng review the latest phase 3 efficacy data from the HAWK/HARRIER, ARCHWAY, and CEDAR/SEQUOIA studies. Also, Dr. Weng shares the case of a wet AMD patient whose response to therapy and toleration of treatment burden mandated a change in treatment. Could brolucizumab (Beovu, Novartis) be a solution?

Arshad M. Khanani, MD, MA, leads a roundtable consisting of Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA, as they discuss the art of drug choice in wet AMD therapy. The panel discusses how and why they switch therapy in challenging wet AMD cases and reviews how the COVID-19 pandemic has factored into their treatment algorithms. Also, Dr. Fuller shares the case of a wet AMD patient whose waning response to traditional therapy required intervention with an intravitreal dexamethasone implant (Ozurdex, Allergan).

No matter how hard you may try to rehabilitate the ocular surface of your dry eye patients, if you don't get good at-home regimens in place, they may fail treatment. In this episode of To the Point, Leslie and Jackie review the three categories of at-home care products available for chronic dry eye: cleansers, heat products, and nutraceuticals. They discuss different examples from each category and offer advice on how to ensure your patients follow their treatment plan.

The Port Delivery System With Ranibizumab (Genentech) is under investigation for the treatment of wet AMD in the phase 3 ARCHWAY trial, data from which was shared at this year's AAO Annual Meeting. Nancy Holekamp, MD, sits down with NRR to provide a primary analysis of the results of ARCHWAY and discusses safety outcomes.

In this podcast episode, Steven J. Dell, MD*, reviews how the addition of the TECNIS® Multifocal Toric II IOL to the TECNIS® II Platform (Johnson & Johnson Vision) compares to the original lenses.*Steven J. Dell, MD is a paid consultant of Johnson & Johnson Surgical Vision, Inc

Dr. Melissa Barnett and Dr. Tom Arnold talk with guest César Lipener, MD, from São Paulo, Brazil, about his journey of becoming a corneal surgeon and a contact lens specialist. Dr. Lipener shares advice and provides insights on fitting scleral lenses and the potential risks involved.

Alan E. Reider, JD, MPH; John McInnes, MD, JD; and Nancy L. Perkins help ophthalmologists navigate potential compliance risks in ophthalmic practice. The trio discuss the intricacies of physician contracts with manufacturers; take a deep dive into privacy, security, and telehealth; and review noncovered services related to premium IOLs.

Lisa Nijm, MD, JD, Founder and Medical Director of Warrenville EyeCare and LASIK, in Warrenville, Illinois, shares her top 12 tips for elevating the quality of your online presentations, as featured in the September/October 2020 issue of Glaucoma Today.

David Goldman, MD, and a faculty panel including Alice Epitropoulos, MD; Scott Schacter, OD; and Mary Pat Johnson share their pearls on telemedicine efficiency, including the best technologies and their most appropriate applications.

David Goldman, MD, leads a faculty panel including Alice Epitropoulos, MD; Scott Schacter, OD; and Mary Pat Johnson discussing how the COVID-19 pandemic has impacted the billing structure of telemedicine to be much more practice-friendly.

New Retina Radio's John Kitchens, MD, and Jorge Fortun, MD, introduce the premier episode of New Retina Radio Journal Club, a new series dedicated to reviewing the latest papers and how they relate to day to day clinical practice. In this episode, Dr. Fortun is joined by Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD, to discuss two papers that address the role, or lack thereof, of anti-VEGF therapy in the treatment of neovascular age-related macular degeneration and geographic atrophy.

Ophthalmology has faced (and conquered) many challenges throughout its history, but never one with quite as many downstream ramifications as COVID-19 will undoubtedly have. What impacts has the pandemic had on young ophthalmologists' training, and what changes are needed to fill the gaps created by it? Listen in as host Vance Thompson, MD, discusses these topics and more with guests Ralph Chu, MD; Uday Devgan, MD, FACS; and Priyanka Sood, MD.

Listen in as S. Barry Eiden, OD, FAAO; Dorothy Hitchmoth, OD; and Mary Beth Yackey, OD, join host Damon Dierker, OD, for a discussion of the important role that early detection of age-related macular degeneration plays in optimizing patient visual outcomes, and how the ForeseeHome AMD Monitoring Program aids practitioners in this endeavor.

Practices across the United States are seeing an uptick in refractive surgery procedures in recent months. Join host Quentin B. Allen, MD, as he considers the potential factors influencing this trend, how these factors may also affect cataract surgery volume, and which available premium technologies can help to optimize patient outcomes. Featuring guests Tal Raviv, MD, FACS; P. Dee G. Stephenson, MD, FACS; and Keith A. Walter, MD, FACS.

Damon Dierker, OD, FAAO; Josh Johnston, OD, FAAO; Brianna Rhue, OD, FAAO; and Walt Whitley, OD, MBA, FAAO, discuss best implementation practices for telemedicine and speculate about its future based on its versatility.

Ranya Habash, MD; Cathleen McCabe, MD; Blake Williamson, MD; and Roger Zaldivar, MD, discuss lessons learned using telemedicine and how to best hybridize a practice while keeping it simple.

Damon Dierker, OD, FAAO, leads a faculty panel including Josh Johnston, OD, FAAO; Brianna Rhue, OD, FAAO; and Walt Whitley, OD, MBA, FAAO, on the differences between routine care and notable complexities when using telemedicine.

Ranya Habash, MD; Cathleen McCabe, MD; Blake Williamson, MD; and Roger Zaldivar, MD, share their expertise and analyze the best uses of telemedicine.

In this webcast of the Survive & Thrive series, Gary Wörtz, MD, is joined by Cherie Fathy, MD; Nandini Venkateswaran, MD; David Felsted, DO; Dagny Zhu, MD; and guest Uday Devgan, MD, FACS, to talk about performing surgery alone for the first time. Drs. Venkateswaran and Felsted share their recent experiences as first-time solo surgeons, and the others weigh in with advice for the early days of operating independently.

Hunter Cherwek, MD, Vice President of Clinical Services with Orbis International, talks about the recent launch of Orbis International's virtual Flying Eye Hospital training program for eye care providers around the globe, as featured in the September/October 2020 issue of Glaucoma Today.

In this podcast, Prof. Bart Leroy (Belgium), Prof. Isabelle Audo (France) and Prof. Robert Maclaren (UK) discuss the management of patients with inherited retinal diseases (IRDs), from the initial identification of a patient with an IRD and referral to specialist center, through to the confirmation of a diagnosis using genotyping and the long-term implications for the patient of receiving that diagnosis. They discuss the current treatment landscape for patients with IRDs and outline future potential therapies on the horizon.

In this podcast, Prof. Bart Leroy (Belgium), Prof. Isabelle Audo (France) and Prof. Robert Maclaren (UK) discuss the management of patients with inherited retinal diseases (IRDs), from the initial identification of a patient with an IRD and referral to specialist center, through to the confirmation of a diagnosis using genotyping and the long-term implications for the patient of receiving that diagnosis. They discuss the current treatment landscape for patients with IRDs and outline future potential therapies on the horizon.

In this month's episode, Robert Chu, OD, explains how optometry can help to improve efficiency by participating in perioperative cataract surgery care in the article he co-wrote with his brother Richard Chu, DO (0:45). Kayla Karpuk, OD, offers some tips for helping unhappy cataract surgery patients cross the goal line to 20/happy in the article she cowrote with Justin Schweitzer, OD, FAAO, (9:33) and in the last segment of the episode, Tracy Offerdahl, BSc, PharmD, FAAO, provides an update on oral medications used in the COVID-19 era (16:40).

In the latest episode of GlobalEyes, hosts Dr. Melissa Barnett and Dr. Tom Arnold speak with Dr. Annelize van Zyl from Pretoria, South Africa, about her innovative practice and involvement with the Boston Keratoprosthesis. Dr. van Zyl shares her experience with specialty lenses and low vision patients.

Unsure of which tools you should get for your dry eye practice? Hosts Leslie and Jackie give a rundown of the different diagnostic tools you can purchase for your growing dry eye clinic, from low-end to high-end and everything in between, sharing their personal challenges and successes with each.

Eric Brooker, OD, FAAO, and Lisa Feulner, MD, PhD, join Marguerite McDonald, MD, FACS, to discuss their approaches to the education and treatment of patients with advanced ocular surface disease.

Colman R. Kraff, MD; Andrés Benatti, MD; Amir H. Marvasti, MD; Jared R. Younger, MD, MPH; and Erik L. Mertens, MD, FEBOphth take turns discussing the messaging and language they use to educate refractive surgery candidates. Listen in as they explore how to effectively set the stage when talking to patients about refractive surgery, how to advance the refractive surgery field without promoting one type of vision correction procedure over others, and how to capitalize on the resurgence in refractive surgery interest in the time of COVID-19.

Arming patients with knowledge is key to fighting any disease. What happens when a confluence of factors create a breeding ground for an uneducated patient population? John W. Kitchens, MD (United States), is joined by Patricio Schlottmann, MD (Argentina), Nicole Eter, MD (Germany), and Adnan Tufail, MBBS, MD, FRCOphth (United Kingdom) to review tactics for educating patients and battling misinformation in the COVID-19 era.

The COVID-19 pandemic accelerated the use of telemedicine. How has this held up in retina now that we've had more than 6 months of experience under our belts? New Retina Radio host John Kitchens, MD, invites Judy E. Kim, MD; Byron Ladd, MD; and Carl D. Regillo, MD, to review how their practices have used (or not used) telemedicine during the pandemic. Also, Dr. Kitchens asks the panel how they've handled educating patients about the pandemic–and how they've tackled questions of misinformation.

Kateki Vinod, MD, discusses some of the existing and emerging tools for expanding glaucoma diagnosis and management beyond the office, as featured in the July/August 2020 issue of Glaucoma Today.

The conclusion of our two-part special episode of The MOD Pod – Contact Lens Business and Patient Safety in the COVID-19 Era: Redefining Normal. Listen to Rachael Wruble, OD, FAAO, speak with colleagues Brianna Rhue, OD, FAAO; William To, OD; and Justin Weigel, OD, about how they navigated the immediate challenges COVID-19 posed on their contact lens businesses, what protocols they implemented to promote patient and staff safety, and the strategies they used to strengthen their practices through the pandemic and beyond.

James Loden, MD, hosts an important webinar around how ambulatory surgical centers (ASCs) are adapting during the COVID-19 pandemic. Along with Regina Boore, senior vice president of Progressive Surgical Solutions, Albert Castillo, CEO of San Antonio Eye Center, and Todd Albertz, vice president of Surgical and Specialty Services at Cincinnati Eye, Dr. Loden discusses ever-changing safety guidelines, staff considerations, product uses, and more.

Laura Periman, MD, and Derek Cunningham, OD, discuss key aspects of Flarex (Eyevance Pharmaceuticals), a topical ophthalmic treatment for ocular surface inflammation and dry eye disease.